Abstract
Amyloid β (Aβ) protein is the major component of extracellular amyloid plaques which are the main pathological feature of Alzheimer’s disease (AD). Disruption in the clearance of Aβ is associated with its accumulation and aggregation that eventually leads to amyloid plaques formation. Numerous drugs have shown to possess therapeutic potential in the treatment of AD, but indeed these drugs only delay the progression of the disease and display numerous side effects. Recently, phytochemicals have drawn much attention in the treatment of neurodegenerative disorders. Among the various phytochemicals, dietary citrus flavonoids have shown potential useful effects against neurological disorders including AD. Dietary citrus flavonoids exhibit a high amount of minerals, vitamins, and antioxidant contents. The present chapter aims to explore the mechanism of Aβ peptide generation, aggregation, and accumulation as well as their prevention through dietary citrus flavonoids.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, Abe K (2008) Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci Lett 444:280–285. https://doi.org/10.1016/j.neulet.2008.08.052
Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD (2014) Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr 5:404–417. https://doi.org/10.3945/an.113.005603
Ali MY et al (2019) Flavanone glycosides inhibit beta-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Abeta aggregation in the amyloidogenic pathway. Chem Biol Interact 309:108707. https://doi.org/10.1016/j.cbi.2019.06.020
Anderson JP, Chen Y, Kim KS, Robakis NK (1992) An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. J Neurochem 59:2328–2331. https://doi.org/10.1111/j.1471-4159.1992.tb10128.x
Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA (2009) Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer’s disease. J Nutr Biochem 20:269–275. https://doi.org/10.1016/j.jnutbio.2008.03.002
Asai M, Hattori C, Szabo B, Sasagawa N, Maruyama K, Tanuma S, Ishiura S (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun 301:231–235. https://doi.org/10.1016/s0006-291x(02)02999-6
Bakoyiannis I, Daskalopoulou A, Pergialiotis V, Perrea D (2019) Phytochemicals and cognitive health: are flavonoids doing the trick? Biomed Pharmacother 109:1488–1497. https://doi.org/10.1016/j.biopha.2018.10.086
Bertram L, Tanzi RE (2008) Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9:768–778. https://doi.org/10.1038/nrn2494
Bhat WF, Bhat SA, Bano B (2015) Evaluation of polyphenols as possible therapeutics for amyloidoses: comparative analysis of Kaempferol and Catechin. Int J Biol Macromol 81:60–68. https://doi.org/10.1016/j.ijbiomac.2015.07.052
Black RA et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729–733. https://doi.org/10.1038/385729a0
Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B (2000) Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis 7:682–689. https://doi.org/10.1006/nbdi.2000.0321
Bu L, Lephart ED (2005) Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci Lett 385:153–157. https://doi.org/10.1016/j.neulet.2005.05.040
Bush AI et al (1993) A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer’s disease. J Biol Chem 268:16109–16112
Buxbaum JN, Tagoe CE (2000) The genetics of the amyloidoses. Annu Rev Med 51:543–569. https://doi.org/10.1146/annurev.med.51.1.543
Calkins MJ, Reddy PH (2011) Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer’s disease neurons. Biochim Biophys Acta 1812:507–513. https://doi.org/10.1016/j.bbadis.2011.01.007
Canobbio I, Catricala S, Balduini C, Torti M (2011) Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in platelets. Biochim Biophys Acta 1813(3):500–506
Chakraborty S, Basu S (2017) Multi-functional activities of citrus flavonoid narirutin in Alzheimer’s disease therapeutics: an integrated screening approach and in vitro validation. Int J Biol Macromol 103:733–743. https://doi.org/10.1016/j.ijbiomac.2017.05.110
Cirrito JR et al (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913–922. https://doi.org/10.1016/j.neuron.2005.10.028
Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79–84. https://doi.org/10.1038/nn1372
Cruts M et al (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7:43–51. https://doi.org/10.1093/hmg/7.1.43
Cummings J et al (2016) Drug development in Alzheimer’s disease: the path to 2025. Alzheimers Res Ther 8:39. https://doi.org/10.1186/s13195-016-0207-9
Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J Neurol Sci 78:151–164. https://doi.org/10.1016/0022-510x(87)90057-8
DeToma AS, Choi JS, Braymer JJ, Lim MH (2011) Myricetin: a naturally occurring regulator of metal-induced amyloid-beta aggregation and neurotoxicity. ChemBioChem 12:1198–1201. https://doi.org/10.1002/cbic.201000790
Dolev I, Michaelson DM (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A 101:13909–13914. https://doi.org/10.1073/pnas.0404458101
Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution of gamma-secretase activity. Nat Cell Biol 5:486–488. https://doi.org/10.1038/ncb960
Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J Cereb Blood Flow Metab 33:1500–1513. https://doi.org/10.1038/jcbfm.2013.135
Fasman GD, Perczel A, Moore CD (1995) Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates. Proc Natl Acad Sci U S A 92:369–371. https://doi.org/10.1073/pnas.92.2.369
Fedele E, Rivera D, Marengo B, Pronzato MA, Ricciarelli R (2015) Amyloid beta: walking on the dark side of the moon. Mech Ageing Dev 152:1–4. https://doi.org/10.1016/j.mad.2015.09.001
Garcia-Osta A, Alberini CM (2009) Amyloid beta mediates memory formation. Learn Mem 16:267–272. https://doi.org/10.1101/lm.1310209
Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ (2006) Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem 99:438–449. https://doi.org/10.1111/j.1471-4159.2006.04079.x
Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH (2004) Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 52:1520–1525. https://doi.org/10.1021/jf035079g
Holtzman DM et al (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A 97:2892–2897. https://doi.org/10.1073/pnas.050004797
Horowitz RM (1986) Taste effects of flavonoids. Prog Clin Biol Res 213:163–175
Huang Y (2006) Apolipoprotein E and Alzheimer disease. Neurology 66:S79–S85. https://doi.org/10.1212/01.wnl.0000192102.41141.9e
Huang SM, Tsai SY, Lin JA, Wu CH, Yen GC (2012) Cytoprotective effects of hesperetin and hesperidin against amyloid beta-induced impairment of glucose transport through downregulation of neuronal autophagy. Mol Nutr Food Res 56:601–609. https://doi.org/10.1002/mnfr.201100682
Hudson SA, Ecroyd H, Kee TW, Carver JA (2009) The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J 276:5960–5972. https://doi.org/10.1111/j.1742-4658.2009.07307.x
Hunt CE, Turner AJ (2009) Cell biology, regulation and inhibition of beta-secretase (BACE-1). FEBS J 276:1845–1859. https://doi.org/10.1111/j.1742-4658.2009.06929.x
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168–1170. https://doi.org/10.1126/science.6474172
Iadecola C (2003) Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer’s dementia. Cell Mol Neurobiol 23:681–689
Jagota S, Rajadas J (2012) Effect of phenolic compounds against Abeta aggregation and Abeta-induced toxicity in transgenic C. elegans. Neurochem Res 37:40–48. https://doi.org/10.1007/s11064-011-0580-5
Jeong S (2017) Molecular and cellular basis of neurodegeneration in Alzheimer’s disease. Mol Cell 40:613–620. https://doi.org/10.14348/molcells.2017.0096
Jordan J, Galindo MF, Miller RJ, Reardon CA, Getz GS, LaDu MJ (1998) Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18:195–204
Kamenetz F et al (2003) APP processing and synaptic function. Neuron 37:925–937. https://doi.org/10.1016/s0896-6273(03)00124-7
Kelly JW, Balch WE (2003) Amyloid as a natural product. J Cell Biol 161:461–462. https://doi.org/10.1083/jcb.200304074
Kim W, Hecht MH (2006) Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer’s Abeta42 peptide. Proc Natl Acad Sci U S A 103:15824–15829. https://doi.org/10.1073/pnas.0605629103
Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, Lee SE (2005) Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53:8537–8541. https://doi.org/10.1021/jf051985c
Kim JK et al (2010) Protective effects of kaempferol (3,4′,5,7-tetrahydroxyflavone) against amyloid beta peptide (Abeta)-induced neurotoxicity in ICR mice. Biosci Biotechnol Biochem 74:397–401. https://doi.org/10.1271/bbb.90585
Lesne S et al (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357. https://doi.org/10.1038/nature04533
Levy E et al (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126. https://doi.org/10.1126/science.2111584
Li C, Zug C, Qu H, Schluesener H, Zhang Z (2015) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42. https://doi.org/10.1016/j.bbr.2014.12.012
Liu R, Zhang T, Yang H, Lan X, Ying J, Du G (2011) The flavonoid apigenin protects brain neurovascular coupling against amyloid-beta(2)(5)(-)(3)(5)-induced toxicity in mice. J Alzheimers Dis 24:85–100. https://doi.org/10.3233/JAD-2010-101593
Lue LF et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155:853–862. https://doi.org/10.1016/s0002-9440(10)65184-x
Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT (2009) Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 4:227–242. https://doi.org/10.1007/s12263-009-0135-4
Malenka RC (2003) The long-term potential of LTP Nature reviews. Neuroscience 4:923–926. https://doi.org/10.1038/nrn1258
Manzine PR et al (2019) ADAM10 in Alzheimer’s disease: pharmacological modulation by natural compounds and its role as a peripheral marker. Biomed Pharmacother 113:108661. https://doi.org/10.1016/j.biopha.2019.108661
Marini D, Balestrieri F (1995) Multivariate-analysis of flavanone glycosides in citrus juices. Ital J Food Sci 7:255–264
McKay DL, Blumberg JB (2006) A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 20:519–530. https://doi.org/10.1002/ptr.1900
McLean CA et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866
Md S, Gan SY, Haw YH, Ho CL, Wong S, Choudhury H (2018) In vitro neuroprotective effects of naringenin nanoemulsion against beta-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. Int J Biol Macromol 118:1211–1219. https://doi.org/10.1016/j.ijbiomac.2018.06.190
Morley JE, Farr SA (2014) The role of amyloid-beta in the regulation of memory. Biochem Pharmacol 88:479–485. https://doi.org/10.1016/j.bcp.2013.12.018
Mouly PP, Arzouyan CR, Gaydou EM, Estienne JM (1994) Differentiation of citrus juices by factorial discriminant-analysis using liquid-chromatography of flavanone glycosides. J Agric Food Chem 42:70–79. https://doi.org/10.1021/Jf00037a011
Noor H, Cao P, Raleigh DP (2012) Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci 21:373–382. https://doi.org/10.1002/pro.2023
O’Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34:185–204. https://doi.org/10.1146/annurev-neuro-061010-113613
Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res 75:742–750. https://doi.org/10.1002/jnr.20025
Ooghe WC, Detavernier CM (1997) Detection of the addition of Citrus reticulata and hybrids to Citrus sinensis by flavonoids. J Agric Food Chem 45:1633–1637. https://doi.org/10.1021/Jf9606262
Orsucci D, Mancuso M, Ienco EC, Simoncini C, Siciliano G, Bonuccelli U (2013) Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer’s disease. Curr Neurovasc Res 10:76–80
Palmblad M, Westlind-Danielsson A, Bergquist J (2002) Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers. J Biol Chem 277:19506–19510. https://doi.org/10.1074/jbc.M112218200
Patel K, Singh GK, Patel DK (2018) A review on pharmacological and analytical aspects of naringenin. Chin J Integr Med 24:551–560. https://doi.org/10.1007/s11655-014-1960-x
Pocernich CB, Lange ML, Sultana R, Butterfield DA (2011) Nutritional approaches to modulate oxidative stress in Alzheimer’s disease. Curr Alzheimer Res 8:452–469
Puzzo D, Arancio O (2013) Amyloid-beta peptide: Dr. Jekyll or Mr. Hyde? J Alzheimers Dis 33(Suppl 1):S111–S120. https://doi.org/10.3233/JAD-2012-129033
Puzzo D, Gulisano W, Arancio O, Palmeri A (2015) The keystone of Alzheimer pathogenesis might be sought in Abeta physiology. Neuroscience 307:26–36. https://doi.org/10.1016/j.neuroscience.2015.08.039
Qi H et al (1999) Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 283:91–94. https://doi.org/10.1126/science.283.5398.91
Rezai-Zadeh K et al (2009) Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer’s disease beta-amyloid production. J Cell Mol Med 13:574–588. https://doi.org/10.1111/j.1582-4934.2008.00344.x
Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34. https://doi.org/10.1146/annurev.nutr.22.111401.144957
Sawmiller D et al (2016) Diosmin reduces cerebral Abeta levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice. J Neuroimmunol 299:98–106. https://doi.org/10.1016/j.jneuroim.2016.08.018
Selkoe DJ (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 17:489–517. https://doi.org/10.1146/annurev.ne.17.030194.002421
Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106–113. https://doi.org/10.1016/j.bbr.2008.02.016
Sengupta U, Nilson AN, Kayed R (2016) The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42–49. https://doi.org/10.1016/j.ebiom.2016.03.035
Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866–2875. https://doi.org/10.1523/JNEUROSCI.4970-06.2007
Shankar GM et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842. https://doi.org/10.1038/nm1782
Sharoar MG, Thapa A, Shahnawaz M, Ramasamy VS, Woo ER, Shin SY, Park IS (2012) Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J Biomed Sci 19:104. https://doi.org/10.1186/1423-0127-19-104
Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H (2008) Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. J Neurosci Res 86:368–377. https://doi.org/10.1002/jnr.21476
Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962–978. https://doi.org/10.1007/s11095-010-0089-7
Sinha S et al (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:537–540. https://doi.org/10.1038/990114
Sisodia SS, St George-Hyslop PH (2002) gamma-Secretase, Notch, Abeta and Alzheimer’s disease: where do the presenilins fit in? Nat Rev Neurosci 3:281–290. https://doi.org/10.1038/nrn785
Socci V, Tempesta D, Desideri G, De Gennaro L, Ferrara M (2017) Enhancing human cognition with cocoa flavonoids. Front Nutr 4:19. https://doi.org/10.3389/fnut.2017.00019
Spencer JP (2010) The impact of fruit flavonoids on memory and cognition. Br J Nutr 104(Suppl 3):S40–S47. https://doi.org/10.1017/S0007114510003934
Stephan A, Phillips AG (2005) A case for a non-transgenic animal model of Alzheimer’s disease. Genes Brain Behav 4:157–172. https://doi.org/10.1111/j.1601-183X.2004.00113.x
Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612–11622. https://doi.org/10.1074/jbc.M210207200
Tampellini D et al (2009) Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 29:9704–9713. https://doi.org/10.1523/JNEUROSCI.2292-09.2009
Tay WM, da Silva GF, Ming LJ (2013) Metal binding of flavonoids and their distinct inhibition mechanisms toward the oxidation activity of Cu2+-beta-amyloid: not just serving as suicide antioxidants! Inorg Chem 52:679–690. https://doi.org/10.1021/ic301832p
Thal DR, Griffin WS, Braak H (2008) Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12:1848–1862. https://doi.org/10.1111/j.1582-4934.2008.00411.x
Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 572:477–492. https://doi.org/10.1113/jphysiol.2005.103754
Urmoneit B et al (1997) Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Investig 77:157–166
Verdone G et al (2002) The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci 11:487–499. https://doi.org/10.1110/ps.29002
Walsh DM et al (2005) The role of cell-derived oligomers of Abeta in Alzheimer’s disease and avenues for therapeutic intervention. Biochem Soc Trans 33:1087–1090. https://doi.org/10.1042/BST20051087
Wang JB, Wang YM, Zeng CM (2011) Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrils. Biochem Biophys Res Commun 415:675–679. https://doi.org/10.1016/j.bbrc.2011.10.135
Wang D et al (2012) Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer’s disease. Pharmacol Biochem Behav 102:13–20. https://doi.org/10.1016/j.pbb.2012.03.013
Wang DM, Li SQ, Zhu XY, Wang Y, Wu WL, Zhang XJ (2013) Protective effects of hesperidin against amyloid-beta (Abeta) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochem Res 38:1034–1044. https://doi.org/10.1007/s11064-013-1013-4
Williams RJ, Spencer JP (2012) Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52:35–45. https://doi.org/10.1016/j.freeradbiomed.2011.09.010
Yan R et al (1999) Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity. Nature 402:533–537. https://doi.org/10.1038/990107
Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H (2014) Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Neurol Sci 35:741–751. https://doi.org/10.1007/s10072-013-1594-3
Yang W et al (2018) Naringin dihydrochalcone ameliorates cognitive deficits and neuropathology in APP/PS1 transgenic mice. Front Aging Neurosci 10:169. https://doi.org/10.3389/fnagi.2018.00169
Yang Z, Kuboyama T, Tohda C (2019) Naringenin promotes microglial M2 polarization and Abeta degradation enzyme expression. Phytother Res 33:1114–1121. https://doi.org/10.1002/ptr.6305
Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord 6:19–33. https://doi.org/10.1177/1756285612461679
Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G (2001) Deranged expression of molecular chaperones in brains of patients with Alzheimer’s disease. Biochem Biophys Res Commun 280:249–258. https://doi.org/10.1006/bbrc.2000.4109
Yoon I, Lee KH, Cho J (2004) Gossypin protects primary cultured rat cortical cells from oxidative stress- and beta-amyloid-induced toxicity. Arch Pharm Res 27:454–459
Zelus C, Fox A, Calciano A, Faridian BS, Nogaj LA, Moffet DA (2012) Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity. Open Biochem J 6:66–70. https://doi.org/10.2174/1874091X01206010066
Zhang N et al (2018) Protective role of naringenin against Abeta25-35-caused damage via ER and PI3K/Akt-mediated pathways. Cell Mol Neurobiol 38:549–557. https://doi.org/10.1007/s10571-017-0519-8
Zhao M, Ma J, Zhu HY, Zhang XH, Du ZY, Xu YJ, Yu XD (2011) Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Mol Cancer 10:104. https://doi.org/10.1186/1476-4598-10-104
Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L (2013) Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer’s disease mouse model. Molecules 18:9949–9965. https://doi.org/10.3390/molecules18089949
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Javed, H., Ojha, S.K., Jamali, M.C. (2022). Beneficial Effects of Citrus Flavonoids Against Aβ Pathology in Alzheimer’s Disease. In: Ashraf, G.M., Uddin, M.S. (eds) Current Thoughts on Dementia. Springer, Singapore. https://doi.org/10.1007/978-981-16-7606-2_19
Download citation
DOI: https://doi.org/10.1007/978-981-16-7606-2_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7605-5
Online ISBN: 978-981-16-7606-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)